SecBot SecBot
SC 13D/A ·Filed Nov 3, 2026

PTHS

Pelthos Therapeutics Inc.
NEUTRAL
Impact 5/10
Processed14h 25m ago SEC0001193125-26-445875
Activist stake amendment (position change)

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13D/A Filing (Primary)0001193125-26-445875
Document: 0001193125-26-445875-index.html0001193125-26-445875
Document: 0001193125-26-445875.txt0001193125-26-445875
17 reports for PTHS
Performance horizon
75% Hit rate @ T+5 3 of 4 directional calls Went positive at some point 4 of 4 best @ T+20▲ +24.35%Aug 13, 2026
Filters
Rows
Reports for PTHS, sortable and filterable
TypeNow
Nov 3, 2026
today
SC 13D/A
NEUTRAL ★ 5/10
$9.65awaiting T+5awaiting T+5$10.55 (+9.33%)
Oct 30, 2026
4d ago
425
NEUTRAL ★ 3/10
$11.52awaiting T+5awaiting T+5$10.55 (−8.42%)
Oct 30, 2026
5d ago
425
NEUTRAL ★ 6/10
$9.40awaiting T+5awaiting T+5$10.55 (+12.23%)
Oct 30, 2026
5d ago
8-K
NEUTRAL ★ 6/10
$9.40awaiting T+5awaiting T+5$10.55 (+12.23%)
Oct 30, 2026
5d ago
Press Release
NEUTRAL ★ 5/10
$9.40awaiting T+5awaiting T+5$10.55 (+12.23%)
Oct 1, 2026
4w ago
8-K
NEUTRAL ★ 2/10
$20.60 $20.50▼ −0.49%▼ −1.65%$10.55 (−48.79%)
Aug 13, 2026
11w ago
8-K
BEARISH ★ 6/10
$28.95 $26.66▲ +7.91%▲ +5.95%$10.55 (+63.56%)
Aug 3, 2026
13w ago
Press Release
NEUTRAL ★ 1/10
$26.84awaiting T+5awaiting T+5$10.55 (−60.69%)
Jun 17, 2026
19w ago
Insider Cluster
BULLISH ★ 6/10
$29.00 $29.21▲ +0.72%▲ +2.39%$10.55 (−63.62%)
May 28, 2026
22w ago
8-K
NEUTRAL ★ 3/10
$26.47 $25.55▼ −3.48%▼ −0.95%$10.55 (−60.14%)
Showing 10 of 17

US Market Status

Market Open · Closes in 5h 13m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026

Fresh PTHS Intelligence

Analysis is for subscribers only.

Subscribe for Full Access